Last reviewed · How we verify
NCT06188728
Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers
NA trial testing effect of 10 gm psyllium husk fiber twice a day, 30 minutes before breakfast and dinner in Metabolic Disease in 90 participants. Completed in 30 July 2021.
27 May 2021
Quick facts
| Lead sponsor | University of Peshawar |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 90 |
| Start date | 7 September 2020 |
| Primary completion | 27 May 2021 |
| Estimated completion | 30 July 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- effect of 10 gm psyllium husk fiber twice a day, 30 minutes before breakfast and dinner
- Effect of life style modification (Diet, Behavior and physical activity)
- Combined effect of 10 gm Psyllium husk fiber and lifestyle modification
- Control
Conditions studied
- Metabolic Disease — all drugs for Metabolic Disease →
Sponsor
University of Peshawar
Who can join
Adults 40 to 60, any sex, with Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A group of 120 school teachers (male=60, female=60) was divided into four subgroups for sixteen weeks of an interventional study. One group was kept in control while the other three groups were assigned intervention. One group was assigned intervention of lifestyle modification (LSM), the other group assigned the intervention of 5 gm psyllium husk fiber (PSH) two times a day, and the third group assigned the combined intervention of LSM \& PSH. Each group comprised of 30 subjects with equal gender bifurcation (15 male and 15 female).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06188728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Disease
Currently open trials in the same condition.
- NCT06575426 — A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes M · Phase 1, PHASE2 · recruiting
- NCT06938386 — Pilot Haskap Metabolite Timing Project · NA · active not recruiting
- NCT06954298 — Molecular Landscape of Complex Lifestyle Modification · NA · active not recruiting
- NCT06717581 — Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older. · recruiting
- NCT06529965 — Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM · NA · recruiting
Other University of Peshawar trials
Trials by the same sponsor.
- NCT06433440 — Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally · Phase 4 · completed
- NCT04311359 — A Pharmacovigilance Study of Brain Oedema · completed
- NCT04293432 — A Pharmacovigilance Study of Torsade de Pointes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06188728 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Peshawar
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06188728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing